Werewolf Therapeutics, Inc. (HOWL)
0.9796
+0.07
(+7.65%)
USD |
NASDAQ |
Oct 09, 16:00
0.9792
0.00 (0.00%)
After-Hours: 20:00
Werewolf Therapeutics Market Cap : 47.61M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 47.61M |
| October 08, 2026 | 44.23M |
| October 07, 2026 | 44.72M |
| October 06, 2026 | 44.72M |
| October 05, 2026 | 45.20M |
| October 02, 2026 | 45.10M |
| October 01, 2026 | 42.84M |
| September 30, 2026 | 44.82M |
| September 29, 2026 | 44.23M |
| September 28, 2026 | 45.20M |
| September 25, 2026 | 46.65M |
| September 24, 2026 | 47.68M |
| September 23, 2026 | 48.08M |
| September 22, 2026 | 47.72M |
| September 21, 2026 | 47.63M |
| September 18, 2026 | 46.90M |
| September 17, 2026 | 46.80M |
| September 16, 2026 | 44.66M |
| September 15, 2026 | 47.63M |
| September 14, 2026 | 46.55M |
| September 11, 2026 | 47.72M |
| September 10, 2026 | 48.04M |
| September 09, 2026 | 46.90M |
| September 08, 2026 | 47.63M |
| September 04, 2026 | 46.96M |
| Date | Value |
|---|---|
| September 03, 2026 | 45.87M |
| September 02, 2026 | 48.52M |
| September 01, 2026 | 46.53M |
| August 31, 2026 | 45.73M |
| August 28, 2026 | 45.84M |
| August 27, 2026 | 47.18M |
| August 26, 2026 | 48.05M |
| August 25, 2026 | 43.25M |
| August 24, 2026 | 42.93M |
| August 21, 2026 | 42.45M |
| August 20, 2026 | 20.96M |
| August 19, 2026 | 19.89M |
| August 18, 2026 | 19.89M |
| August 17, 2026 | 19.71M |
| August 14, 2026 | 19.67M |
| August 13, 2026 | 18.76M |
| August 12, 2026 | 18.56M |
| August 11, 2026 | 18.65M |
| August 10, 2026 | 18.56M |
| August 07, 2026 | 19.30M |
| August 06, 2026 | 19.58M |
| August 05, 2026 | 19.54M |
| August 04, 2026 | 20.15M |
| August 03, 2026 | 17.86M |
| July 31, 2026 | 17.16M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.856B |
| Oncolytics Biotech, Inc. | 69.42M |
| Sangamo Therapeutics, Inc. | 61.22M |
| Sarepta Therapeutics, Inc. | 1.885B |
| Anixa Biosciences, Inc. | 100.30M |
Market Cap Related Metrics
| PS Ratio | 2.242 |
| Price to Book Value | 2.922 |
| Price | 0.9796 |
| Earnings Yield | -75.40% |